Yashaswini, Chittampalli N.
Mitran, Bogdan
Papadopoulos, Natalia
Wegrzyniak, Olivia
Löfblom, John
Nordström, Helena
Velikyan, Irina
Abouzayed, Ayman
Johansson, Lars
Hagmar, Per
Wagner, Michael
Frejd, Fredrik Y.
Korsgren, Olle
Heldin, Carl-Henrik
Friedman, Scott L.
Eriksson, Olof https://orcid.org/0000-0002-2515-8790
Funding for this research was provided by:
Uppsala University
Article History
Received: 10 June 2025
Accepted: 1 December 2025
First Online: 13 December 2025
Declarations
:
: All the performed procedures were in accordance with the ARRIVE guidelines for animal research. The animal experiments were ethically reviewed, authorized by the Animal Ethics Committee of the Swedish Animal Welfare Agency and carried out in accordance with the European Directive 2010/63/EEC and the institutional guidelines at Uppsala University (UFV 2007/724).All human biological sample donors in Sweden provide informed consent that their donated tissues may be entered into a BioBank and used in medical research, pending review and approval by the Swedish Ethical Review Authority of individual studies. The use of human liver tissues from Uppsala Biobank (registration #827) was approved by the Swedish Ethical Review Authority (2019-02790) and were anonymized, collected, and treated according to local institutional and Swedish national rules and regulations.
: Not applicable.
: MW, OK and OE are co-founders and minority shareholders of Antaros Tracer AB. BM, AA and PH are employees of Antaros Tracer AB. LJ is co-founder, minority shareholder and employee of Antaros Medical AB. The remaining authors declare that they have no competing interest.